Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Chimeric Therapeutics Limited has announced the application for quotation of 13,333,334 ordinary fully paid securities under the ASX security code CHM, with an issue date of June 28, 2024. This move signifies the company’s progression in the financial markets, potentially attracting investors who are keeping an eye on promising stock opportunities.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.
